Financhill
Sell
44

ASTH Quote, Financials, Valuation and Earnings

Last price:
$24.7100
Seasonality move :
58834.16%
Day range:
$24.5000 - $25.4550
52-week range:
$23.1200 - $63.2000
Dividend yield:
0%
P/E ratio:
35.11x
P/S ratio:
0.54x
P/B ratio:
1.57x
Volume:
293.5K
Avg. volume:
264.6K
1-year change:
-50.38%
Market cap:
$1.2B
Revenue:
$2B
EPS (TTM):
$0.72

Earnings Data

Next earnings date for ASTH
Aug 07
2025
Most recent earnings per share
$0.14
Missed by $0.19
(May 8/2025)
Consensus Estimate
$0.33
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ASTH Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
09/30/2025 Q3 $933.9M -- -- $0.52 --
08/07/2025 Q2 $639.1M -- -- $0.48 --
05/08/2025 Q1 $630.7M $620.4M $0.14 $0.33 -$0.19
02/27/2025 Q4 $617.2M $665.2M -$0.15 $0.21 -$0.36
11/07/2024 Q3 $462.4M $478.7M $0.33 $0.38 -$0.05
08/07/2024 Q2 $440.8M $486.3M $0.40 $0.56 -$0.16
05/07/2024 Q1 $413.8M $404.4M $0.31 $0.29 $0.02
02/27/2024 Q4 $341.2M $353M $0.26 $0.22 $0.04
09/30/2023 Q3 $350.1M $348.2M $0.47 $0.32 $0.15
06/30/2023 Q2 $342.9M $348.2M $0.28 $0.35 -$0.07
03/31/2023 Q1 -- $337.2M $0.28 -- --
12/31/2022 Q4 -- $294.2M -$0.06 -- --
09/30/2022 Q3 -- $317M $0.50 -- --
06/30/2022 Q2 -- $269.7M $0.26 -- --
03/31/2022 Q1 -- $263.3M $0.30 -- --
12/31/2021 Q4 -- $195.1M $0.30 -- --
09/30/2021 Q3 -- $227.1M $0.74 -- --
06/30/2021 Q2 -- $175.6M $0.28 -- --
03/31/2021 Q1 -- $176.1M $0.30 -- --
12/31/2020 Q4 -- -$140.1M $0.27 -- --
09/30/2020 Q3 -- $180.1M $0.45 -- --
06/30/2020 Q2 -- $165.2M $0.19 -- --
03/31/2020 Q1 -- $165.1M $0.11 -- --
12/31/2019 Q4 -- $178.8M $0.18 -- --
09/30/2019 Q3 -- $156.1M $0.10 -- --
06/30/2019 Q2 -- $130.1M $0.09 -- --
03/31/2019 Q1 -- $95.8M $0.00 -- --
12/31/2018 Q4 -- $105.5M -$0.10 -- --
09/30/2018 Q3 -- $167.3M $0.24 -- --
06/30/2018 Q2 -- $123M $0.08 -- --
03/31/2018 Q1 -- $124.2M $0.07 -- --
09/30/2017 Q3 -- $40.5M -$0.64 -- --
06/30/2017 Q2 -- $41.6M -$0.60 -- --
03/31/2017 Q1 -- $14.8M -$0.76 -- --
12/31/2016 Q4 -- $15.7M -$0.29 -- --
09/30/2016 Q3 -- $14.6M -$0.23 -- --
06/30/2016 Q2 -- $12.4M -$0.22 -- --
03/31/2016 Q1 -- $11.8M -$0.79 -- --
12/31/2015 Q4 -- $10.7M -$0.31 -- --
09/30/2015 Q3 -- $11.4M -$0.11 -- --

Astrana Health Earnings Questions

  • How Much did Astrana Health Generate in Revenue Last Quarter?

    Astrana Health reported $620.4M worth of top line sales in its most recent quarter.

  • Did Astrana Health Beat Earnings Last Quarter?

    Astrana Health announced earnings per share of $0.14 which represents a miss of analyst forecast a $0.33 per share.

  • Is Astrana Health Profitable?

    Astrana Health reported $71.3M that represents $1.46 per share over the last quarter.

  • What is the Analyst Consensus for Astrana Health EPS Next Year?

    Astrana Health's earnings are forecast to grow from $0.90 per share to $1.79 per share next year representing an increase of 113.33%.

  • When is Astrana Health's Earnings Date?

    Astrana Health's next earnings date is August 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will GoodRX Stock Bounce Back?
Will GoodRX Stock Bounce Back?

GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…

Will FCX Benefit From Tariffs?
Will FCX Benefit From Tariffs?

Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…

Can Levi Stock Double?
Can Levi Stock Double?

Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…

Stock Ideas

Buy
70
Is NVDA Stock a Buy?

Market Cap: $4.2T
P/E Ratio: 58x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 43x

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 35x

Alerts

Buy
82
SBET alert for Jul 17

SharpLink Gaming [SBET] is down 2.6% over the past day.

Buy
89
EXOD alert for Jul 17

Exodus Movement [EXOD] is down 4.14% over the past day.

Buy
60
U alert for Jul 17

Unity Software [U] is up 7.51% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock